Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ (2012) Epidemiology of dementias and alzheimer’s disease. Arch Med Res 43(8):600–608. https://doi.org/10.1016/j.arcmed.2012.11.003

Article  PubMed  Google Scholar 

Hao Wei Y, Yi YH et al (2013) Psychiatry [M]. Page seven. People’s Medical Publishing House, Beijing, pp 56–57

Google Scholar 

Prince M, Wimo A, Guerchet M, Claire Ali G, Wu Y-T, Prina M (2015) World alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer’s Disease International (ADI), London

Google Scholar 

Savarino V, Marabotto E, Zentilin P et al (2018) The appropriate use of proton-pump inhibitors. Minerva Med 109(5):386–399. https://doi.org/10.23736/S0026-4806.18.05705-1

Article  PubMed  Google Scholar 

Maideen NMP (2023) Adverse effects associated with Long-Term use of proton pump inhibitors. Chonnam Med J 59(2):115–127. https://doi.org/10.4068/cmj.2023.59.2.115

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu LY, Sun LN, Zhang XH et al (2017) A review of the novel application and potential adverse effects of proton pump inhibitors. Adv Ther 34(5):1070–1086. https://doi.org/10.1007/s12325-017-0532-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomm W, von Holt K, Thomé F et al (2016) Association of proton pump inhibitors with risk of dementia: A pharmacoepidemiological claims data analysis. JAMA Neurol 73(4):410–416. https://doi.org/10.1001/jamaneurol.2015.4791

Article  PubMed  Google Scholar 

Haenisch B, von Holt K, Wiese B et al (2015) Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci 265(5):419–428. https://doi.org/10.1007/s00406-014-0554-0

Article  PubMed  Google Scholar 

Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P (2016) Proton pump inhibitors and risk of dementia. Ann Transl Med 4(12):240. https://doi.org/10.21037/atm.2016.06.14

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tai SY, Chien CY, Wu DC et al (2017) Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan. PLoS ONE 12(2):e0171006 Published 2017 Feb 15. https://doi.org/10.1371/journal.pone.0171006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pourhadi N, Janbek J, Jensen-Dahm C, Gasse C, Laursen TM, Waldemar G (2024) Proton pump inhibitors and dementia: A nationwide population-based study. Alzheimers Dement 20(2):837–845. https://doi.org/10.1002/alz.13477

Article  CAS  PubMed  Google Scholar 

Welu J, Metzger J, Bebensee S, Ahrendt A, Vasek M (2019) Proton pump inhibitor use and risk of dementia in the veteran population. Fed Pract 36(Suppl 4):S27–S31

PubMed  PubMed Central  Google Scholar 

Goldstein FC, Steenland K, Zhao L, Wharton W, Levey AI, Hajjar I (2017) Proton pump inhibitors and risk of mild cognitive impairment and dementia. J Am Geriatr Soc 65(9):1969–1974. https://doi.org/10.1111/jgs.14956

Article  PubMed  PubMed Central  Google Scholar 

Yu Sisi L, Zheng L, Miaomiao (2019) etc. Meta-analysis of the association between Proton-pump inhibitor and the risk of dementia or Alzheimer disease [ J ]. Chinese general practice, 22(23): 2861–2865

Park SK, Baek YH, Pratt N, Kalisch Ellett L, Shin JY (2018) The uncertainty of the association between proton pump inhibitor use and the risk of dementia: prescription sequence symmetry analysis using a Korean healthcare database between 2002 and 2013. Drug Saf 41(6):615–624. https://doi.org/10.1007/s40264-018-0638-2

Article  CAS  PubMed  Google Scholar 

Taipale H, Tolppanen AM, Tiihonen M, Tanskanen A, Tiihonen J, Hartikainen S (2017) No association between proton pump inhibitor use and risk of alzheimer’s disease. Am J Gastroenterol 112(12):1802–1808. https://doi.org/10.1038/ajg.2017.196

Article  CAS  PubMed  Google Scholar 

Lochhead P, Hagan K, Joshi AD et al (2017) Association between proton pump inhibitor use and cognitive function in women. Gastroenterology 153(4):971–979e4. https://doi.org/10.1053/j.gastro.2017.06.061

Article  CAS  PubMed  Google Scholar 

Hwang IC, Chang J, Park SM (2018) A nationwide Population-Based cohort study of dementia risk among acid suppressant users. Am J Geriatr Psychiatry 26(11):1175–1183. https://doi.org/10.1016/j.jagp.2018.06.002

Article  PubMed  Google Scholar 

Gray SL, Walker RL, Dublin S et al (2018) Proton pump inhibitor use and dementia risk: prospective Population-Based study. J Am Geriatr Soc 66(2):247–253. https://doi.org/10.1111/jgs.15073

Article  PubMed  Google Scholar 

Imfeld P, Bodmer M, Jick SS, Meier CR (2018) Proton pump inhibitor use and risk of developing alzheimer’s disease or vascular dementia: A Case-Control analysis. Drug Saf 41(12):1387–1396. https://doi.org/10.1007/s40264-018-0704-9

Article  CAS  PubMed  Google Scholar 

Ma C, Shaheen AA, Congly SE, Andrews CN, Moayyedi P, Forbes N (2020) Interpreting reported risks associated with use of proton pump inhibitors: residual confounding in a 10-Year analysis of National ambulatory data. Gastroenterology 158(3):780–782e3. https://doi.org/10.1053/j.gastro.2019.10.023

Article  PubMed  Google Scholar 

Li M, Luo Z, Yu S, Tang Z (2019) Proton pump inhibitor use and risk of dementia: systematic review and meta-analysis. Med (Baltim) 98(7):e14422. https://doi.org/10.1097/MD.0000000000014422

Article  Google Scholar 

Booker A, Jacob LE, Rapp M, Bohlken J, Kostev K (2016) Risk factors for dementia diagnosis in German primary care practices. Int Psychogeriatr 28(7):1059–1065. https://doi.org/10.1017/S1041610215002082

Article  PubMed  Google Scholar 

Cooksey R, Kennedy J, Dennis MS et al (2020) Proton pump inhibitors and dementia risk: evidence from a cohort study using linked routinely collected National health data in wales, UK. PLoS ONE 15(9):e0237676 Published 2020 Sep 18. https://doi.org/10.1371/journal.pone.0237676

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tobin MD, Minelli C, Burton PR, Thompson JR (2004) Commentary: development of Mendelian randomization: from hypothesis test to ‘mendelian deconfounding’. Int J Epidemiol 33(1):26–29. https://doi.org/10.1093/ije/dyh016

Article  PubMed  Google Scholar 

Burgess S, Small DS, Thompson SG (2017) A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res 26(5):2333–2355. https://doi.org/10.1177/0962280215597579

Article  PubMed  Google Scholar 

Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601 Published 2018 Jul 12. https://doi.org/10.1136/bmj.k601

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR (2016) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45(6):1961–1974. https://doi.org/10.1093/ije/dyw220

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665. https://doi.org/10.1002/gepi.21758

Article  PubMed  PubMed Central  Google Scholar 

Zagkos L, Dib MJ, Pinto R et al (2022) Associations of genetically predicted fatty acid levels across the phenome: A Mendelian randomisation study. PLoS Med 19(12):e1004141 Published 2022 Dec 29. https://doi.org/10.1371/journal.pmed.1004141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314. https://doi.org/10.1002/gepi.21965

Article  PubMed